Article
Title Date
Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities.
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma
Refinement of the endogenous epitope tagging technology allows the identification of a novel NRAS binding partner in melanoma.
Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma.
RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens
Parkin Somatic Mutations Link Melanoma and Parkinson's Disease
Parkinson disease (PARK) genes are somatically mutated in cutaneous melanoma
Recurrent inactivating RASA2 mutations in melanoma
Refinement of the endogenous epitope tagging technology allows the identification of a novel NRAS binding partner in melanoma
The functional relevance of somatic synonymous mutations in melanoma and other cancer
A highly recurrent RPS27 5’UTR mutation in melanoma.
Somatic Mutation of GRIN2A in Malignant Melanoma Results in Loss of Tumor Suppressor Activity via Aberrant NMDAR Complex Formation
Signatures of historical demography and pathogen richness on MHC class I genes